1. Home
  2. CGEN vs DHX Comparison

CGEN vs DHX Comparison

Compare CGEN & DHX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGEN
  • DHX
  • Stock Information
  • Founded
  • CGEN 1993
  • DHX 1991
  • Country
  • CGEN Israel
  • DHX United States
  • Employees
  • CGEN N/A
  • DHX N/A
  • Industry
  • CGEN Biotechnology: Biological Products (No Diagnostic Substances)
  • DHX Business Services
  • Sector
  • CGEN Health Care
  • DHX Consumer Discretionary
  • Exchange
  • CGEN Nasdaq
  • DHX Nasdaq
  • Market Cap
  • CGEN 125.3M
  • DHX 143.1M
  • IPO Year
  • CGEN 2000
  • DHX 2007
  • Fundamental
  • Price
  • CGEN $1.95
  • DHX $2.03
  • Analyst Decision
  • CGEN
  • DHX Strong Buy
  • Analyst Count
  • CGEN 0
  • DHX 2
  • Target Price
  • CGEN N/A
  • DHX $5.25
  • AVG Volume (30 Days)
  • CGEN 560.3K
  • DHX 412.2K
  • Earning Date
  • CGEN 11-11-2025
  • DHX 11-11-2025
  • Dividend Yield
  • CGEN N/A
  • DHX N/A
  • EPS Growth
  • CGEN N/A
  • DHX N/A
  • EPS
  • CGEN N/A
  • DHX N/A
  • Revenue
  • CGEN $22,144,000.00
  • DHX $134,396,000.00
  • Revenue This Year
  • CGEN N/A
  • DHX N/A
  • Revenue Next Year
  • CGEN $208.08
  • DHX N/A
  • P/E Ratio
  • CGEN N/A
  • DHX N/A
  • Revenue Growth
  • CGEN N/A
  • DHX N/A
  • 52 Week Low
  • CGEN $1.13
  • DHX $1.21
  • 52 Week High
  • CGEN $2.66
  • DHX $3.34
  • Technical
  • Relative Strength Index (RSI)
  • CGEN 60.17
  • DHX 26.47
  • Support Level
  • CGEN $1.30
  • DHX $1.99
  • Resistance Level
  • CGEN $2.38
  • DHX $2.19
  • Average True Range (ATR)
  • CGEN 0.17
  • DHX 0.18
  • MACD
  • CGEN 0.04
  • DHX -0.08
  • Stochastic Oscillator
  • CGEN 57.00
  • DHX 7.04

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.

About DHX DHI Group Inc.

DHI Group Inc is a provider of artificial intelligence-powered software products, online tools and services to deliver career marketplaces to candidates and employers globally. DHI's brands includes Dice and Clearance Jobs enable recruiters and hiring managers to efficiently search, match and connect with skilled technologists in specialized fields, particularly technology and those with active government security clearances. The company derive the majority of revenue came from the sale of recruitment packages, which allow customers to promote jobs on websites and source candidates through their resume databases. Recruitment packages are typically provided through contractual arrangements with annual, quarterly or monthly payment terms.

Share on Social Networks: